Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 75 M79 M95 M80 M78 M80 M 333 M Research & development —————— — Operating income 120 M80 M18 M-9 M34 M31 M 74 M Non-Operating Income, Total -6 M-10 M3 M-5 M9 M9 M 16 M Interest expense, net of interest capitalized 3 M4 M4 M6 M4 M4 M 18 M Non-Operating Income, excl. Interest Expenses -4 M-7 M0-9 M2 M4 M -3 M Unusual income/expense -5 M-7 M-1 M-2 M3 M1 M 1 M Pretax income 116 M73 M18 M-11 M36 M34 M 77 M Equity in earnings 000—00 — Taxes 26 M19 M9 M-4 M9 M8 M 22 M Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations 91 M54 M9 M-8 M27 M26 M 54 M Discontinued operations —————— — Net income 91 M54 M9 M-8 M27 M26 M 54 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 91 M54 M9 M-8 M27 M26 M 54 M Basic earnings per share (Basic EPS) 1.30.770.13-0.110.390.38 0.79 Diluted earnings per share (Diluted EPS) 1.30.770.13-0.120.390.38 0.78 Average basic shares outstanding 70 M70 M70 M70 M70 M70 M — Diluted shares outstanding 70 M70 M70 M70 M70 M70 M — EBITDA 123 M79 M20 M—71 M66 M — EBIT 86 M43 M-16 M-16 M33 M27 M 28 M Cost of revenue 526 M577 M534 M482 M459 M549 M 2.02 B Other cost of goods sold —————— — Depreciation & amortization (cash flow) 35 M36 M36 M—38 M39 M —